From The Industry Experts
-
Evaluating Usability And Incorporating The Patient Experience In DECODE-Nocturnal Scratch
4/22/2024
The DECODE-Nocturnal Scratch group, launched in November 2023, aims to introduce a purpose-built digital measure of nocturnal scratching to enhance patient-focused drug development in dermatology and provide deeper clinical insights.
-
Backup Sites: The Closers Of Clinical Trials
4/22/2024
With the rising complexity of trials and dwindling site availability, the adoption of backup sites has become increasingly commonplace, reflecting the industry's commitment to maximizing recruitment potential.
-
Considerations For Plain Language Summaries
4/22/2024
Recent FDA emphasis on plain language underscores a shift towards greater transparency and patient understanding, highlighted in the joint FDA and Office for Human Research Protections (OHRP) draft guidance.
-
Diversity In Clinical Trials: Walking The Walk
4/22/2024
Discover why achieving true diversity demands more than rhetoric—requiring genuine engagement, cultural humility, and a commitment to understanding and addressing the unique needs of marginalized communities.
-
Efficient Data Aggregation & Oversight: A CRO Success Story
4/22/2024
Explore how a full-service CRO & tech-driven life sciences provider streamlined data aggregation & clinical trial oversight, yielding significant time and cost savings.
-
Breaking The Mold: How R Is Revolutionizing CSR Generation
4/22/2024
The open-source statistical programming language R is becoming more popular in the life sciences sector for clinical study report submissions due to its cost-effectiveness, inclusivity, and collaboration.
-
Yes, Women’s Exclusion In Clinical Trials Is Still A Problem
4/22/2024
Despite the progress made in including women in clinical trials, challenges persist. Hera Biotech CEO Somer Baburek explains why the fight for inclusion isn't over.
-
Bringing Clinical Research To The Patient Using Patient-Centric Tech
4/19/2024
By fostering daily interactions between patients and technology, these smart hubs offer a sustainable approach to ensuring the success and integrity of clinical trials in an evolving landscape of drug development.
-
Why In The World Should You Come to San Diego?
4/19/2024
With over 180 sessions across 13 tracks and nine engaging learning formats, attendees will delve into emerging fields such as precision medicine, regulatory CMC, and product quality, and value-based access.
-
Reporting To The IRB: Investigator Noncompliance
4/19/2024
Reporting noncompliance concerns is crucial to protect research participants. By promptly reporting noncompliance, researchers can ensure ethical research conduct and protect the rights and welfare of participants.